Tiziana Life Sciences (TLSA) Total Liabilities (2017 - 2025)
Tiziana Life Sciences (TLSA) posted quarterly Total Liabilities of $11.4 million for Q4 2025, up 55.73% year-over-year from $7.3 million in Q4 2024, and up 54.7% quarter-over-quarter from $7.4 million in Q2 2025.
Tiziana Life Sciences (TLSA) Total Liabilities (2017 - 2025) Analysis & Trends
Tiziana Life Sciences' Total Liabilities history runs 9 years deep, the most recent figure standing at $11.4 million for Q4 2025.
- In Q4 2025, Total Liabilities rose 55.73% year-over-year to $11.4 million; the TTM figure through Dec 2025 stood at $11.4 million (up 55.73% YoY), while the FY2025 annual figure was $11.4 million, up 55.73% from the prior year.
- Total Liabilities for Q4 2025 stood at $11.4 million, up from $7.4 million in the prior quarter.
- The five-year high for Total Liabilities was $11.4 million in Q4 2025, with the low at $4.1 million in Q2 2023.
- The 5-year median for Total Liabilities is $7.4 million (2024), against an average of $7.5 million.
- The sharpest annual moves came in 2022 and 2024: Total Liabilities tumbled 42.41% in 2022, then soared 120.93% in 2024.
- Tiziana Life Sciences' Total Liabilities stood at $7.5 million in 2021, then declined by 8.48% to $6.9 million in 2022, then decreased by 3.74% to $6.6 million in 2023, then climbed by 10.53% to $7.3 million in 2024, then jumped by 55.73% to $11.4 million in 2025.
- Business Quant data shows TLSA's Total Liabilities at $11.4 million in Q4 2025, $7.4 million in Q2 2025, and $7.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Tiziana Life Sciences | 133.66 Mn | 129.65 Mn | - | 11.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.44 Mn |
| Jun 30, 2025 | 7.40 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Jun 30, 2024 | 9.11 Mn |
| Dec 31, 2023 | 6.65 Mn |
| Jun 30, 2023 | 4.12 Mn |
| Dec 31, 2022 | 6.91 Mn |
| Jun 30, 2022 | 5.28 Mn |
| Dec 31, 2021 | 7.55 Mn |
| Jun 30, 2021 | 9.16 Mn |
| Dec 31, 2020 | 8.00 Mn |
| Jun 30, 2020 | 6.89 Mn |
| Dec 31, 2019 | 7.70 Mn |
| Jun 30, 2019 | 6.55 Mn |
| Dec 31, 2018 | 6.47 Mn |
| Jun 30, 2018 | 6.17 Mn |
| Dec 31, 2017 | 2.43 Mn |